(NAMC) - ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) announced on April 4, 2007 the pricing of its public offering of 5,750,000 shares of its common stock. The public offering price of $15.50 per share will result in gross proceeds of $89.1 million and net proceeds, after underwriting commissions and other offering expenses, of $83.5 million to ACADIA. ACADIA also granted the underwriters a 30-day option to purchase up to 862,500 additional shares of its common stock, which could raise the net proceeds to ACADIA to $96.1 million, if exercised in full. All of the shares are being sold by ACADIA.

 
Wall Street to Main Street is also one of the leading shows on StreetIQ , the leader in financial podcast: http://www.streetiq.com/dir/NAMC.shtml

Also be sure to listen to the "Wall Street to Main Street" radio show that is syndicated daily. Just visit the NAMC radio at www.namcnewswire.com/namcradio. 

U.S. Trade Delegations to China scheduled for 2007, Small and Mid Cap Public and Private U.S. Companies are the Focus of the trips: www.namcworldwide.com/conferences